|
Summary of continuous outcomes for sildenafil, tadalafil and vardenafil |
||||
| Sildenafil |
||||
| Number of |
||||
| Outcome |
Dose |
Trials |
Patients |
Weighted mean |
|
|
||||
| Percentage successful attempts |
placebo |
16 |
1448 |
23 |
| 50/100 |
16 |
1589 |
65 |
|
| Erectile function domain score |
placebo |
23 |
1870 |
14.0 |
| 50/100 |
23 |
1893 |
22.0 |
|
| Erectile function domain change |
placebo |
23 |
1870 |
2.7 |
| 50/100 |
23 |
1893 |
10.1 |
|
| Tadalafil |
||||
| Number of |
||||
|
|
||||
| Outcome |
Dose |
Trials |
Patients |
Weighted mean |
|
|
||||
| Percentage successful attempts |
placebo |
6 |
388 |
26 |
| 10/20 |
6 |
1047 |
62 |
|
| Erectile function domain score |
placebo |
6 |
388 |
14.6 |
| 10/20 |
6 |
1047 |
22.3 |
|
| Erectile function domain change |
placebo |
7 |
459 |
0.8 |
| 10/20 |
7 |
1192 |
8.4 |
|
| Vardenafil |
||||
| Number of |
||||
|
|
||||
| Outcome |
Dose |
Trials |
Patients |
Weighted mean |
|
|
||||
| Percentage successful attempts |
placebo |
7 |
996 |
28 |
| 10/20 |
7 |
1789 |
59 |
|
| Erectile function domain score |
placebo |
7 |
996 |
14.0 |
| 10/20 |
7 |
1789 |
20.1 |
|
| Erectile function domain change |
placebo |
7 |
996 |
1.3 |
| 10/20 |
7 |
1344 |
8.3 |
|
Moore et al. BMC Urology 2005 5:18 doi:10.1186/1471-2490-5-18 |
||||